Chlamydia trachomatis Pgp3 Antibody Population Seroprevalence before and during an Era of Widespread Opportunistic Chlamydia Screening in England (1994-2012)

• Sarah C. Woodhall ,

  Contributed equally to this work with: Sarah C. Woodhall, Gillian S. Wills

  * E-mail: sarah.woodhall@phe.gov.uk (SW); anne.johnson@ucl.ac.uk (AMJ)

  Affiliations National Infection Service, Public Health England, London, United Kingdom, Research Department of Infection and Population Health, UCL, London, United Kingdom

  http://orcid.org/0000-0001-7896-3526

  ⨯
• Gillian S. Wills ,

  Contributed equally to this work with: Sarah C. Woodhall, Gillian S. Wills

  Affiliation Jefferiss Research Trust Laboratories, Faculty of Medicine, Imperial College London, St Mary's Campus, London, United Kingdom

  ⨯
• Patrick J. Horner,

  Affiliation School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom

  ⨯
• Rachel Craig,

  Affiliation NatCen Social Research, London, United Kingdom

  ⨯
• Jennifer S. Mindell,

  Affiliation Research Department of Epidemiology and Public Health, UCL, London, United Kingdom

  ⨯
• Gary Murphy,

  Affiliation National Infection Service, Public Health England, London, United Kingdom

  ⨯
• Myra O. McClure,

  Affiliation Jefferiss Research Trust Laboratories, Faculty of Medicine, Imperial College London, St Mary's Campus, London, United Kingdom

  ⨯
• Kate Soldan,

  Affiliation National Infection Service, Public Health England, London, United Kingdom

  ⨯
• Anthony Nardone ,

  ¶‡ These authors also contributed equally to this work.

  Affiliation National Infection Service, Public Health England, London, United Kingdom

  ⨯
• Anne M. Johnson

  * E-mail: sarah.woodhall@phe.gov.uk (SW); anne.johnson@ucl.ac.uk (AMJ)

  ¶‡ These authors also contributed equally to this work.

  Affiliation Research Department of Infection and Population Health, UCL, London, United Kingdom

  ⨯